We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 14, 2021

Poziotinib for EGFR and HER2 Exon 20 Insertion Mutation in Advanced NSCLC

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Poziotinib for EGFR and HER2 Exon 20 Insertion Mutation in Advanced NSCLC: Results From the Expanded Access Program
Eur. J. Cancer 2021 Apr 02;[EPub Ahead of Print], A Prelaj, A Bottiglieri, C Proto, G Lo Russo, D Signorelli, R Ferrara, G Galli, A De Toma, G Viscardi, M Brambilla, R Lobefaro, F Nichetti, S Manglaviti, M Occhipinti, A Labianca, M Ganzinelli, R Gallucci, N Zilembo, GF Greco, V Torri, F de Braud, MC Garassino

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading